Individualization of Adjuvant Therapy After Radical Prostatectomy for Clinically Localized Prostate Cancer: Current Status and Future Directions

Clinical Genitourinary Cancer
Darrion L MitchellJohn M Watkins

Abstract

Radiation therapy indications in the postprostatectomy setting are evolving. Several retrospective series have identified a number of "high-risk" pathologic features associated with an elevated risk of disease recurrence after radical prostatectomy. More recently, several randomized phase III trials demonstrated superior biochemical relapse-free survival for adjuvant radiation therapy after prostatectomy for patients with these high-risk pathologic features, including positive margin status, extraprostatic extension, and/or seminal vesicle invasion. These series further suggested improvement in distant metastasis control and overall survival after 15 years. However, not all patients with high-risk features experience disease recurrence after surgery alone, and some subsets of patients experience suboptimal disease control and survival despite immediate postoperative radiotherapy. Furthermore, some patients without high-risk features will develop recurrence. The present review discusses the current data and potential future directions to improve individualization of therapy after prostatectomy.

References

Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Dec 7, 2000·Journal of the National Cancer Institute·S SignorettiM Loda
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M RoachUNKNOWN Radiation Therapy Oncology Group 9413
May 12, 2004·Urology·Oliver SartorUNKNOWN Quadramet 424Sm10/11 Study Group
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Michael HaganEndre Z. Neulander
Jun 3, 2004·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Apr 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Miljenko V PilepichDavid Grignon
Aug 16, 2005·Lancet·Michel BollaUNKNOWN European Organization for Research and Treatment of Cancer
Aug 23, 2005·International Journal of Radiation Oncology, Biology, Physics·Rex CheungDeborah Kuban
Dec 27, 2005·Gene·Nicola NormannoDavid S Salomon
Jun 6, 2006·The Lancet Oncology·Edward M MessingUNKNOWN Eastern Cooperative Oncology Group study EST 3886
Nov 16, 2006·JAMA : the Journal of the American Medical Association·Ian M ThompsonE David Crawford
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J StephensonAlan Pollack
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pascal PommierChristian Carrie
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel C DanilaHoward I Scher
Dec 20, 2007·American Journal of Clinical Pathology·Jonathan I EpsteinUNKNOWN Association of Directors of Anatomic and Surgical Pathology
Mar 4, 2008·International Journal of Radiation Oncology, Biology, Physics·Michael J ZelefskyHoward I Amols
Dec 23, 2008·International Journal of Radiation Oncology, Biology, Physics·Alan C HartfordUNKNOWN American College of Radiology
Feb 20, 2009·Molecular Biology of the Cell·Justin M DrakeMichael D Henry
May 26, 2009·International Journal of Radiation Oncology, Biology, Physics·Johnny Ray BernardThomas M Pisansky
Sep 22, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Filippo AlongiNadia Di Muzio

❮ Previous
Next ❯

Citations

Sep 22, 2016·Clinical Epigenetics·Milan S GeybelsJanet L Stanford
Mar 17, 2017·American Journal of Clinical Oncology·Amar U KishanChristopher R King
Dec 2, 2017·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Calum MacAulayBranko Palcic
Dec 7, 2018·Journal of Racial and Ethnic Health Disparities·Charnita Zeigler-JohnsonKaren Glanz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Related Papers

Seminars in Radiation Oncology
Matthew C Abramowitz, Alan Pollack
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology
Naotaka SakamotoSeiji Naito
Hematology/oncology Clinics of North America
Elaine T Lam, L Michael Glode
© 2021 Meta ULC. All rights reserved